Nonsense-Mediated mRNA Decay and Ubiquitin-Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

被引:133
作者
Vignier, Nicolas [2 ,3 ]
Schlossarek, Saskia [1 ]
Fraysse, Bodvael [2 ,3 ]
Mearini, Giulia [1 ]
Kraemer, Elisabeth [1 ]
Pointu, Herve
Mougenot, Nathalie [3 ]
Guiard, Josiane
Reimer, Rudolph
Hohenberg, Heinrich [6 ]
Schwartz, Ketty [2 ]
Vernet, Muriel [4 ,5 ]
Eschenhagen, Thomas [1 ]
Carrier, Lucie [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Cardiovasc Res Ctr, D-20246 Hamburg, Germany
[2] INSERM, U582, U974, Paris, France
[3] Univ Paris 06, CNRS, UMR S974, UMR 7215,IFR14,Inst Myol, Paris, France
[4] Commissariat Energie Atom Grenoble, iRTSV, Grenoble, France
[5] Commissariat Energie Atom Fontenay, iRCM, Fontenay Aux Roses, France
[6] Univ Hamburg, Heinrich Pette Inst, Hamburg, Germany
关键词
cardiomyopathy; hypertrophic cardiomyopathy; mRNA stability; transgenic mice; ubiquitin; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SPLICE DONOR SITE; DILATED CARDIOMYOPATHY; SEPTAL HYPERTROPHY; IN-VIVO; MUTATIONS; GENE; IMPAIRMENT; ORGANIZATION; TRANSCRIPTS;
D O I
10.1161/CIRCRESAHA.109.201251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Mutations in the MYBPC3 gene encoding cardiac myosin-binding protein (cMyBP)-C are frequent causes of hypertrophic cardiomyopathy, but the mechanisms leading from mutations to disease remain elusive. Objective: The goal of the present study was therefore to gain insights into the mechanisms controlling the expression of MYBPC3 mutations. Methods and Results: We developed a cMyBP-C knock-in mouse carrying a point mutation. The level of total cMyBP-C mRNAs was 50% and 80% lower in heterozygotes and homozygotes, respectively. Surprisingly, the single G>A transition on the last nucleotide of exon 6 resulted in 3 different mutant mRNAs: missense (exchange of G for A), nonsense (exon skipping, frameshift, and premature stop codon) and deletion/insertion (as nonsense but with additional partial retention of downstream intron, restoring of the reading frame, and almost full-length protein). Inhibition of nonsense-mediated mRNA decay in cultured cardiac myocytes or in vivo with emetine or cycloheximide increased the level of nonsense mRNAs severalfold but not of the other mRNAs. By using sequential protein fractionation and a new antibody directed against novel amino acids produced by the frameshift, we showed that inhibition of the proteasome with epoxomicin via osmotic minipumps increased the level of (near) full-length mutants but not of truncated proteins. Homozygotes exhibited myocyte and left ventricular hypertrophy, reduced fractional shortening, and interstitial fibrosis; heterozygotes had no major phenotype. Conclusions: These data reveal (1) an unanticipated complexity of the expression of a single point mutation in the whole animal and (2) the involvement of both nonsense-mediated mRNA decay and the ubiquitin-proteasome system in lowering the level of mutant proteins. (Circ Res. 2009; 105: 239-248.)
引用
收藏
页码:239 / U89
页数:23
相关论文
共 44 条
  • [1] Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics
    Alcalai, Ronny
    Seidman, Jonathan G.
    Seidman, Christine E.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (01) : 104 - 110
  • [2] Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency
    Andersen, PS
    Havndrup, O
    Bundgaard, H
    Larsen, LA
    Vuust, J
    Pedersen, AK
    Kjeldsen, K
    Christiansen, M
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (08) : 673 - 677
  • [3] PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts
    Asai, Mitsutoshi
    Tsukamoto, Osamu
    Minamino, Tetsuo
    Asanuma, Hiroshi
    Fujita, Masashi
    Asano, Yoshihiro
    Takahama, Hiroyuki
    Sasaki, Hideyuki
    Higo, Shuichiro
    Asakura, Masanori
    Takashima, Seiji
    Hori, Masatsugu
    Kitakaze, Masafumi
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (04) : 452 - 462
  • [4] Ubipuitin-Proteasome System Impairment Caused by a Missense Cardiac Myosin-binding Protein C Mutation and Associated with Cardiac Dysfunction in Hypertrophic Cardiomyopathy
    Bahrudin, Udin
    Morisaki, Hiroko
    Morisaki, Takayuki
    Ninomiya, Haruaki
    Higaki, Katsumi
    Nanba, Eiji
    Igawa, Osamu
    Takashima, Seiji
    Mizutas, Einosuke
    Miake, Junichiro
    Yamamoto, Yasutaka
    Shirayoshi, Yasuaki
    Kitakaze, Masafumi
    Carrier, Lucie
    Hisatome, Ichiro
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2008, 384 (04) : 896 - 907
  • [5] BELLO NF, 2009, CELL DEATH DIFFER
  • [6] Disruption of the regulatory β subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality
    Buchou, T
    Vernet, M
    Blond, O
    Jensen, HH
    Pointu, H
    Olsen, BB
    Cochet, C
    Issinger, OG
    Boldyreff, B
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (03) : 908 - 915
  • [7] Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice
    Carrier, L
    Knöll, R
    Vignier, N
    Keller, DI
    Bausero, P
    Prudhon, B
    Isnard, R
    Ambroisine, ML
    Fiszman, M
    Ross, J
    Schwartz, K
    Chien, KR
    [J]. CARDIOVASCULAR RESEARCH, 2004, 63 (02) : 293 - 304
  • [8] Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
    Carrier, L
    Bonne, G
    Bahrend, E
    Yu, B
    Richard, P
    Niel, F
    Hainque, B
    Cruaud, C
    Gary, F
    Labeit, S
    Bouhour, JB
    Dubourg, O
    Desnos, M
    Hagege, AA
    Trent, RJ
    Komajda, M
    Fiszman, M
    Schwartz, K
    [J]. CIRCULATION RESEARCH, 1997, 80 (03) : 427 - 434
  • [9] Carrier L, 2007, ARCH MAL COEUR VAISS, V100, P238
  • [10] A REGULATORY MECHANISM THAT DETECTS PREMATURE NONSENSE CODONS IN T-CELL RECEPTOR TRANSCRIPTS IN-VIVO IS REVERSED BY PROTEIN-SYNTHESIS INHIBITORS IN-VITRO
    CARTER, MS
    DOSKOW, J
    MORRIS, P
    LI, SL
    NHIM, RP
    SANDSTEDT, S
    WILKINSON, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) : 28995 - 29003